Bone and Renal health in infants with or without breastmilk exposure to Tenofovir based maternal antiretroviral treatment in the PROMISE randomized trial

No Thumbnail Available

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Lippincott, Williams & Wilkins (LWW)

Abstract

Description

Keywords

Citation

Vhembo, T., Baltrusaitis, K., Tierney, C., Owor, M., Dadabhai, S., Violari, A., Theron, G., Moodley, D., Mukwasi-Kahari, C., George, K., Shepherd, J., Siberry, G. K., Browning, R., Fowler, M. G., Stranix-Chibanda, L., & IMPAACT P1084s study team (2023). Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial. Journal of Acquired Immune Deficiency Syndrome (1999), 93(5), 431–437.

Endorsement

Review

Supplemented By

Referenced By